247 related articles for article (PubMed ID: 22881387)
21. Age, sex, and nutritional status modify the CD4+ T-cell recovery rate in HIV-tuberculosis co-infected patients on combination antiretroviral therapy.
Ezeamama AE; Mupere E; Oloya J; Martinez L; Kakaire R; Yin X; Sekandi JN; Whalen CC
Int J Infect Dis; 2015 Jun; 35():73-9. PubMed ID: 25910854
[TBL] [Abstract][Full Text] [Related]
22. CD4 cell count recovery in HIV/TB co-infected patients versus TB uninfected HIV patients.
Wanchu A; Kuttiatt VS; Sharma A; Singh S; Varma S
Indian J Pathol Microbiol; 2010; 53(4):745-9. PubMed ID: 21045406
[TBL] [Abstract][Full Text] [Related]
23. [Impact of etiotropic therapy on the immune status of patients with HIV infection and tuberculosis].
Zimina VN; Kravchenko AV
Ter Arkh; 2015; 87(11):37-41. PubMed ID: 26821414
[TBL] [Abstract][Full Text] [Related]
24. Neuropsychiatric manifestations among HIV-1 infected African patients receiving efavirenz-based cART with or without tuberculosis treatment containing rifampicin.
Mugusi S; Ngaimisi E; Janabi M; Mugusi F; Minzi O; Aris E; Bakari M; Bertilsson L; Burhenne J; Sandstrom E; Aklillu E
Eur J Clin Pharmacol; 2018 Nov; 74(11):1405-1415. PubMed ID: 30003275
[TBL] [Abstract][Full Text] [Related]
25. Safety and antiretroviral effectiveness of concomitant use of rifampicin and efavirenz for antiretroviral-naive patients in India who are coinfected with tuberculosis and HIV-1.
Patel A; Patel K; Patel J; Shah N; Patel B; Rani S
J Acquir Immune Defic Syndr; 2004 Sep; 37(1):1166-9. PubMed ID: 15319677
[TBL] [Abstract][Full Text] [Related]
26. Type 1 helper T cells and FoxP3-positive T cells in HIV-tuberculosis-associated immune reconstitution inflammatory syndrome.
Meintjes G; Wilkinson KA; Rangaka MX; Skolimowska K; van Veen K; Abrahams M; Seldon R; Pepper DJ; Rebe K; Mouton P; van Cutsem G; Nicol MP; Maartens G; Wilkinson RJ
Am J Respir Crit Care Med; 2008 Nov; 178(10):1083-9. PubMed ID: 18755923
[TBL] [Abstract][Full Text] [Related]
27. Pre-HAART CD4+ T-lymphocytes as biomarkers of post-HAART immune recovery in HIV-infected children with or without TB co-infection.
Gopalakrishnan V; Bose E; Nair U; Cheng Y; Ghebremichael M
BMC Infect Dis; 2020 Oct; 20(1):756. PubMed ID: 33059622
[TBL] [Abstract][Full Text] [Related]
28. Impact of hepatitis C virus coinfection on T-cell dynamics in long-term HIV-suppressors under combined antiretroviral therapy.
Zaegel-Faucher O; Bregigeon S; Cano CE; Obry-Roguet V; Nicolino-Brunet C; Tamalet C; Dignat-George F; Poizot-Martin I
AIDS; 2015 Jul; 29(12):1505-10. PubMed ID: 26244390
[TBL] [Abstract][Full Text] [Related]
29. Biomarkers of CD4+ T-cell activation as risk factors for tuberculosis-associated immune reconstitution inflammatory syndrome.
Chakrabarti LA; Boucherie C; Bugault F; Cumont MC; Roussillon C; Breton G; Patey O; Chêne G; Richert L; Lortholary O;
AIDS; 2014 Jul; 28(11):1593-602. PubMed ID: 24865974
[TBL] [Abstract][Full Text] [Related]
30. Safety of monitoring antiretroviral therapy response in HIV-1 infection using CD4+ T cell count at long-term intervals.
Vogler IH; Alfieri DF; Gianjacomo HDB; Almeida ERD; Reiche EMV
Cad Saude Publica; 2018 Oct; 34(10):e00009618. PubMed ID: 30365742
[TBL] [Abstract][Full Text] [Related]
31. Safety and immunogenicity of the M72/AS01 candidate tuberculosis vaccine in HIV-infected adults on combination antiretroviral therapy: a phase I/II, randomized trial.
Thacher EG; Cavassini M; Audran R; Thierry AC; Bollaerts A; Cohen J; Demoitié MA; Ejigu D; Mettens P; Moris P; Ofori-Anyinam O; Spertini F
AIDS; 2014 Jul; 28(12):1769-81. PubMed ID: 24911353
[TBL] [Abstract][Full Text] [Related]
32. Risk factors for 'unmasking immune reconstitution inflammatory syndrome' presentation of tuberculosis following combination antiretroviral therapy initiation in HIV-infected patients.
Valin N; Pacanowski J; Denoeud L; Lacombe K; Lalande V; Fonquernie L; Girard PM; Meynard JL
AIDS; 2010 Jun; 24(10):1519-25. PubMed ID: 20549841
[TBL] [Abstract][Full Text] [Related]
33. Risk of tuberculosis after antiretroviral treatment initiation: a comparison between efavirenz and nevirapine using inverse probability weighting.
Hermans SM; Manabe YC; Kiragga AN; Hoepelman AI; Lange JM; van Leth F
Antivir Ther; 2013; 18(4):615-22. PubMed ID: 23423604
[TBL] [Abstract][Full Text] [Related]
34. [The value of changes in CD8+CD28+ and CD4+CD28+ cells in patients with HIV infection concurrent with tuberculosis during treatment].
Popova AA; Kravchenko AV; Kozhevnikova GM; Zimina VN
Ter Arkh; 2013; 85(11):54-7. PubMed ID: 24432600
[TBL] [Abstract][Full Text] [Related]
35. CD4 cell levels during treatment for tuberculosis (TB) in Ethiopian adults and clinical markers associated with CD4 lymphocytopenia.
Skogmar S; Schön T; Balcha TT; Jemal ZH; Tibesso G; Björk J; Björkman P
PLoS One; 2013; 8(12):e83270. PubMed ID: 24358268
[TBL] [Abstract][Full Text] [Related]
36. Robust Reconstitution of Tuberculosis-Specific Polyfunctional CD4+ T-Cell Responses and Rising Systemic Interleukin 6 in Paradoxical Tuberculosis-Associated Immune Reconstitution Inflammatory Syndrome.
Ravimohan S; Tamuhla N; Nfanyana K; Steenhoff AP; Letlhogile R; Frank I; MacGregor RR; Gross R; Weissman D; Bisson GP
Clin Infect Dis; 2016 Mar; 62(6):795-803. PubMed ID: 26611774
[TBL] [Abstract][Full Text] [Related]
37. Recent trends in early stage response to combination antiretroviral therapy in Australia.
McManus H; Hoy JF; Woolley I; Boyd MA; Kelly MD; Mulhall B; Roth NJ; Petoumenos K; Law MG;
Antivir Ther; 2015; 20(2):131-9. PubMed ID: 24704818
[TBL] [Abstract][Full Text] [Related]
38. Effects of antiretroviral therapy on immune function of HIV-infected adults with pulmonary tuberculosis and CD4+ >350 cells/mm3.
Lancioni CL; Mahan CS; Johnson DF; Walusimbi M; Chervenak KA; Nalukwago S; Charlebois E; Havlir D; Mayanja-Kizza H; Whalen CC; Boom WH
J Infect Dis; 2011 Apr; 203(7):992-1001. PubMed ID: 21402550
[TBL] [Abstract][Full Text] [Related]
39. Human immunodeficiency virus-1 RNA levels and CD4 lymphocyte counts, during treatment for active tuberculosis, in South African patients.
Morris L; Martin DJ; Bredell H; Nyoka SN; Sacks L; Pendle S; Page-Shipp L; Karp CL; Sterling TR; Quinn TC; Chaisson RE
J Infect Dis; 2003 Jun; 187(12):1967-71. PubMed ID: 12792875
[TBL] [Abstract][Full Text] [Related]
40. Mycobacterium tuberculosis microbiologic and clinical treatment outcomes in a randomized trial of immediate versus CD4(+)-initiated antiretroviral therapy in HIV-infected adults with a high CD4(+) cell count.
Chamie G; Charlebois ED; Srikantiah P; Walusimbi-Nanteza M; Mugerwa RD; Mayanja H; Okwera A; Whalen CC; Havlir DV
Clin Infect Dis; 2010 Aug; 51(3):359-62. PubMed ID: 20569064
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
